Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Asthma”

353 trials

Showing 20 of 353 results

Large-scale testing (Phase 3)Study completedNCT00254956
What this trial is testing

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

Who this might be right for
Respiratory Tract DiseasesRespiratory HypersensitivityAsthma
Sanofi 1,568
Testing effectiveness (Phase 2)Study completedNCT01296087
What this trial is testing

TC-6987 for the Treatment of Mild to Moderate Asthma

Who this might be right for
Asthma
Targacept Inc. 203
Testing effectiveness (Phase 2)Study completedNCT00507130
What this trial is testing

Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma

Who this might be right for
Asthma
MedImmune LLC 36
Testing effectiveness (Phase 2)Study completedNCT00927901
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT02301975
What this trial is testing

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Who this might be right for
Asthma
GlaxoSmithKline 1,526
Testing effectiveness (Phase 2)Study completedNCT01772368
What this trial is testing

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Who this might be right for
Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT01233284
What this trial is testing

Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.

Who this might be right for
Asthma
Boehringer Ingelheim 149
Testing effectiveness (Phase 2)Study completedNCT00443482
What this trial is testing

Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)

Who this might be right for
Asthma
Novartis 50
Large-scale testing (Phase 3)Study completedNCT00394368
What this trial is testing

EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI

Who this might be right for
Bronchial Asthma
Chiesi Farmaceutici S.p.A. 180
Post-approval studies (Phase 4)Study completedNCT04997304
What this trial is testing

Teva Asthma Predictive Analytics Study

Who this might be right for
Asthma
University of Michigan 100
Large-scale testing (Phase 3)Study completedNCT01147848
What this trial is testing

HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents

Who this might be right for
Asthma
GlaxoSmithKline 810
Post-approval studies (Phase 4)Study completedNCT00760838
What this trial is testing

AZISAST Study: AZIthromycin in Severe ASThma Study

Who this might be right for
Asthma
University Hospital, Ghent 109
Large-scale testing (Phase 3)Study completedNCT00476268
What this trial is testing

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 824
Post-approval studies (Phase 4)Study completedNCT00691873
What this trial is testing

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Post-approval studies (Phase 4)Study completedNCT00329381
What this trial is testing

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Not applicableStudy completedNCT00536705
What this trial is testing

Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma

Who this might be right for
Asthma
Shanghai Jiao Tong University School of Medicine 112
Testing effectiveness (Phase 2)WithdrawnNCT00689806
What this trial is testing

Evaluation of Lovastatin in Severe Persistent Asthma

Who this might be right for
Severe Persistent Asthma
University of Chicago
Testing effectiveness (Phase 2)WithdrawnNCT00675649
What this trial is testing

A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma

Who this might be right for
Asthma
Centocor, Inc.
Not applicableStudy completedNCT03860519
What this trial is testing

The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma

Who this might be right for
Asthma
Endeavor Health 100
Post-approval studies (Phase 4)Ended earlyNCT02953106
What this trial is testing

Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis

Who this might be right for
Asthma, AllergicRhinitis,AllergicAllergy
University of Dundee 7
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation